Literature DB >> 6825543

Polymorphonuclear leukocyte function in ulcerative colitis and Crohn's disease.

A P Kirk, J Cason, J N Fordham, K A Brown, D H Goddard, E J Holborow, J E Lennard-Jones.   

Abstract

The aim of this study was to determine whether polymorphonuclear leukocyte chemotaxis, adhesion, and electrophoretic mobility were altered in inflammatory bowel disease and whether such alterations could be related to prior ingestion of immune complexes. Polymorphonuclear leukocytes from patients with ulcerative colitis and Crohn's disease showed significantly impaired stimulated migration (P less than 0.05), increased adhesiveness (P less than 0.01 in ulcerative colitis, P less than 0.001 in Crohn's disease), and reduced electrophoretic mobility (P less than 0.02 in ulcerative colitis, P less than 0.001 in Crohn's disease) compared with healthy controls. The disease control of patients with rheumatoid arthritis demonstrated reduced stimulated migration (P less than 0.025) but normal adhesion. Preincubating normal cells in inflammatory bowel disease sera suggested that the altered migration and adhesion were due to circulating serum factors. Circulating immune complexes, detected by the C1q PEG binding assay, were present in 12.5% of patients with ulcerative colitis and 30% with Crohn's disease. Direct immunofluorescence of polymorphonuclear leukocytes suggested binding and/or ingestion of complexes in 57% of patients with ulcerative colitis, and 67% with Crohn's disease. There was a direct correlation between positive immunofluorescence and impaired cell migration in ulcerative colitis (P less than 0.05), but no such relationship was found in the other parameters of polymorph function.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6825543     DOI: 10.1007/bf01295119

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  40 in total

1.  Immune complexes in ulcerative colitis and Crohn's disease.

Authors:  H J Hodgson; B J Potter; D P Jewell
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

2.  An electron microscopic study of inflammatory colonic disease.

Authors:  J J O'Connor
Journal:  Dis Colon Rectum       Date:  1972 Jul-Aug       Impact factor: 4.585

3.  The neutrophil adherence assay as a method for detecting unique anti-inflammatory agents.

Authors:  V J Stecher; G L Chinea
Journal:  Agents Actions       Date:  1978-04

4.  Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.

Authors:  R H Zubler; G Lange; P H Lambert; P A Miescher
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

5.  Neutrophil function in children with kwashiorkor.

Authors:  K Schopfer; S D Douglas
Journal:  J Lab Clin Med       Date:  1976-09

6.  Chronic immune colitis in rabbits.

Authors:  A S Mee; J E McLaughlin; H J Hodgson; D P Jewell
Journal:  Gut       Date:  1979-01       Impact factor: 23.059

7.  A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis.

Authors:  J Powell-Tuck; R L Bown; J E Lennard-Jones
Journal:  Scand J Gastroenterol       Date:  1978       Impact factor: 2.423

8.  The leucocyte chemotactic function in patients with ulcerative colitis.

Authors:  V Binder; P Riis
Journal:  Scand J Gastroenterol       Date:  1977       Impact factor: 2.423

9.  Chemotaxis of polymorphonuclear leukocytes from patients with rheumatoid arthritis.

Authors:  A G Mowat; J Baum
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

10.  Skin reactivity and phagocytic function of neutrophil leucocytes in Crohn's disease and ulcerative colitis.

Authors:  U Krause; G Michaëlsson; L Juhlin
Journal:  Scand J Gastroenterol       Date:  1978       Impact factor: 2.423

View more
  10 in total

1.  Polymorphonuclear leucocytes in Crohn's disease and ulcerative proctocolitis: association between enhanced adherence to nylon fibre and disease variables.

Authors:  J Cason; C C Ainley; R A Wolstencroft; R P Thompson
Journal:  J Clin Pathol       Date:  1988-03       Impact factor: 3.411

Review 2.  Phagocytes, toxic oxygen metabolites and inflammatory bowel disease: implications for treatment.

Authors:  J G Williams
Journal:  Ann R Coll Surg Engl       Date:  1990-07       Impact factor: 1.891

3.  Toxic oxygen metabolite production by circulating phagocytic cells in inflammatory bowel disease.

Authors:  J G Williams; L E Hughes; M B Hallett
Journal:  Gut       Date:  1990-02       Impact factor: 23.059

Review 4.  Circulating neutrophils from patients with ulcerative colitis have a normal respiratory burst.

Authors:  J M Haydek; A Keshavarzian
Journal:  Inflammation       Date:  1995-12       Impact factor: 4.092

5.  'Conversion' from ulcerative colitis to Crohn's disease associated with corticosteroid treatment.

Authors:  A D Dwarakanath; J Nash; J M Rhodes
Journal:  Gut       Date:  1994-08       Impact factor: 23.059

6.  Comparison of fecal granulocyte excretion in ulcerative colitis and Crohn's colitis.

Authors:  S H Saverymuttu; H J Hodgson; V S Chadwick
Journal:  Dig Dis Sci       Date:  1984-11       Impact factor: 3.199

7.  In vivo assessment of granulocyte migration to diseased bowel in Crohn's disease.

Authors:  S H Saverymuttu; A M Peters; J P Lavender; V S Chadwick; H J Hodgson
Journal:  Gut       Date:  1985-04       Impact factor: 23.059

8.  Alterations in rat peripheral blood neutrophil function as a consequence of colitis.

Authors:  L Carter; J L Wallace
Journal:  Dig Dis Sci       Date:  1995-01       Impact factor: 3.199

9.  Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content.

Authors:  H W Verspaget; A S Peña; I T Weterman; C B Lamers
Journal:  Gut       Date:  1988-02       Impact factor: 23.059

10.  Nanogels of a Succinylated Glycol Chitosan-Succinyl Prednisolone Conjugate: Release Behavior, Gastrointestinal Distribution, and Systemic Absorption.

Authors:  Haiyan Zhou; Yuri Ikeuchi-Takahashi; Yoshiyuki Hattori; Hiraku Onishi
Journal:  Int J Mol Sci       Date:  2020-03-30       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.